MA22927A1 - PROCESS FOR THE PREPARATION OF NEW COMPOUNDS. - Google Patents

PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.

Info

Publication number
MA22927A1
MA22927A1 MA23217A MA23217A MA22927A1 MA 22927 A1 MA22927 A1 MA 22927A1 MA 23217 A MA23217 A MA 23217A MA 23217 A MA23217 A MA 23217A MA 22927 A1 MA22927 A1 MA 22927A1
Authority
MA
Morocco
Prior art keywords
preparation
new compounds
compounds
new
Prior art date
Application number
MA23217A
Other languages
French (fr)
Inventor
Alan Holt Dennis
Alan Levy Mark
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MA22927A1 publication Critical patent/MA22927A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA23217A 1992-06-30 1993-06-28 PROCESS FOR THE PREPARATION OF NEW COMPOUNDS. MA22927A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929213835A GB9213835D0 (en) 1992-06-30 1992-06-30 Compounds

Publications (1)

Publication Number Publication Date
MA22927A1 true MA22927A1 (en) 1994-04-01

Family

ID=10717920

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23217A MA22927A1 (en) 1992-06-30 1993-06-28 PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.

Country Status (23)

Country Link
EP (1) EP0651643A4 (en)
JP (1) JPH08500821A (en)
KR (1) KR950702118A (en)
CN (1) CN1095382A (en)
AP (1) AP412A (en)
AU (1) AU4545993A (en)
BG (1) BG99313A (en)
BR (1) BR9306748A (en)
CA (1) CA2138956A1 (en)
CZ (1) CZ334694A3 (en)
FI (1) FI946189A (en)
GB (1) GB9213835D0 (en)
HU (1) HUT69409A (en)
IL (1) IL106158A0 (en)
MA (1) MA22927A1 (en)
MX (1) MX9303970A (en)
NO (1) NO945074L (en)
OA (1) OA10122A (en)
RU (1) RU94046378A (en)
SI (1) SI9300350A (en)
SK (1) SK159994A3 (en)
WO (1) WO1994000125A1 (en)
ZA (1) ZA934645B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925774A (en) 1991-01-07 1999-07-20 Pherin Corporation Estrenes for inducing hypothalamic effects
EP0646007B1 (en) * 1992-05-20 1997-08-13 Merck & Co. Inc. NEW DELTA-17 AND DELTA-20 OLEFINIC AND SATURATED 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONES AS 5$g(a)-REDUCTASE INHIBITORS
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic
JP2015129095A (en) 2013-12-19 2015-07-16 ロレアル composition
CN114805462A (en) * 2018-02-11 2022-07-29 江苏豪森药业集团有限公司 Steroid derivative regulator and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors

Also Published As

Publication number Publication date
NO945074D0 (en) 1994-12-29
AU4545993A (en) 1994-01-24
CZ334694A3 (en) 1995-10-18
FI946189A0 (en) 1994-12-30
WO1994000125A1 (en) 1994-01-06
JPH08500821A (en) 1996-01-30
CN1095382A (en) 1994-11-23
BR9306748A (en) 1998-12-08
MX9303970A (en) 1994-04-29
EP0651643A1 (en) 1995-05-10
SI9300350A (en) 1993-12-31
NO945074L (en) 1995-02-16
SK159994A3 (en) 1996-01-10
HUT69409A (en) 1995-09-28
ZA934645B (en) 1994-01-25
KR950702118A (en) 1995-06-19
BG99313A (en) 1995-09-29
AP9300542A0 (en) 1993-07-31
FI946189A (en) 1994-12-30
OA10122A (en) 1996-12-18
CA2138956A1 (en) 1994-01-06
GB9213835D0 (en) 1992-08-12
IL106158A0 (en) 1993-10-20
AP412A (en) 1995-09-29
EP0651643A4 (en) 1995-10-04
RU94046378A (en) 1996-10-10

Similar Documents

Publication Publication Date Title
MA22922A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23270A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA22923A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23792A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA24011A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA23802A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA22970A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA24426A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
FR2691326B1 (en) PROCESS FOR THE PRODUCTION OF ANTIMICROBIAL COMPOUNDS.
MA22955A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23254A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA23143A1 (en) PROCESS FOR THE PREPARATION OF VACCINATION COMPOSITIONS.
MA22860A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23770A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA21645A1 (en) PROCESS FOR THE PREPARATION OF NEW RTEMISININ DERIVATIVES.
FR2740132B1 (en) PROCESS FOR THE PREPARATION OF 1,1,1,3,3-PENTAFLUOROPROPANE
MA24427A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA23309A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.
MA23041A1 (en) PROCESS FOR THE PREPARATION OF SUBSTITUTED BENZOPYRANIC COMPOUNDS.
MA24355A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS
MA21348A1 (en) PROCESS FOR THE PREPARATION OF NEW AMINOALCOXYPHENYL DERIVATIVES.
MA23134A1 (en) PROCESS FOR THE PREPARATION OF ARYL-PIPERIDINE CARBINOLS.
MA23036A1 (en) PROCESS FOR THE PREPARATION OF COMPOUNDS.
MA21984A1 (en) PROCESS FOR THE PREPARATION OF QUILINONE DERIVATIVES.
MA22927A1 (en) PROCESS FOR THE PREPARATION OF NEW COMPOUNDS.